Delivery Order SPE2DE21D7020-SPE2D625F0UDP
Award Date 8/12/25
Potential Completion Date 8/19/25
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $7,593.10 for EnRoute TCAR stents on August 14, 2025. This fixed-price contract with economic price adjustment is scheduled for ultimate completion by August 21, 2025, and will be performed at Boston Scientific's Marlborough facility. The award is being funded through the Defense Health Agency's Medical Supply Chain, a defense-focused federal...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $3,326.30 to Boston Scientific Corp for EnRoute TCAR stents on July 25, 2025, with an ultimate completion date of August 1, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures...
- This federal contract award was issued by the Defense Health Agency (DHA) to Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts. The $3,796.55 fixed-price with economic price adjustment delivery order contract is for the provision of ENROUTE TCAR STENTS, which are specialized medical devices used in cardiovascular procedures. The contract has an ultimate completion date of July 16, 2025 and was awarded on July 9, 2025. It is not designated...
- This is a federal contract award to Boston Scientific Corp, a global medical technology company, by the Defense Health Agency (DHA) for the delivery of ENROUTE TCAR stents. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and a ceiling value of $3,796.55. The contract does not have a set-aside designation. The performance period extends to June 10, 2025. Boston Scientific is also the holder of two federal Indefinite Delivery Vehicles (IDVs) with...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $3,010.72 for wallstents under the Defense Health Agency's Medical Supply Chain program. The contract, awarded on August 11, 2025, with an ultimate completion date of August 18, 2025, utilizes fixed-price pricing with economic price adjustment. This delivery order represents part of Boston Scientific's broader federal portfolio, which encompasses...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,303.44 by the Defense Health Agency's Medical Supply Chain program. This fixed-price contract with economic price adjustment, issued on July 28, 2025, is scheduled for completion by August 4, 2025. The award represents a non-set-aside competitive procurement, with performance occurring at Boston Scientific's Marlborough facility. As a...
- Boston Scientific Corp, a Marlborough, Massachusetts-based global medical technology company, was awarded a delivery order by the Defense Health Agency's Medical Supply Chain on July 22, 2025, with an ultimate completion date of July 29, 2025. The contract, valued at $1,727.26, is structured as a fixed price agreement with economic price adjustment provisions and carries no set-aside designation, indicating open competition in the federal marketplace. The award description references medical...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $13,027.08 by the Defense Health Agency's Medical Supply Chain on August 4, 2025. The contract, which utilizes fixed-price pricing with economic price adjustment, is scheduled for completion by August 11, 2025. The award represents a non-set-aside competitive procurement, and the place of performance is Boston Scientific's facility in Marlborough, MA. As...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a $3,201.54 fixed-price delivery order (Contract No. 4568919661, designated INTERLOCK 35) by the Defense Health Agency's Medical Supply Chain program. The delivery order, effective through August 5, 2025, represents a continuation of Boston Scientific's role as a critical supplier of advanced medical devices to federal healthcare agencies. This non-set-aside award reflects...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $7,669.40 by the Defense Health Agency's Medical Supply Chain on July 29, 2025, with an ultimate completion date of August 5, 2025. The contract, designated as 4568924698 for NG synthetic MR US 38MM medical supplies, represents a non-competitive award with no set-aside designation. Boston Scientific will perform this work at its...